Occidental Petroleum Corporation (OXY) remains a harder name to own than some classic Buffett holdings because commodity prices can swing the earnings profile quickly. Even so, the latest results show why the company can still fit a long-term, value-focused framework: a stronger balance sheet, disciplined production, reserve depth, and the ability to generate cash even in a softer price backdrop.
Why Buffett’s Interest in Occidental Still Makes Strategic Sense
The case for Occidental is not that it is immune to oil cycles. It clearly is not. The case is that the company has spent the last few years trying to make that cyclicality more manageable through debt reduction, operating discipline, and portfolio moves that improve financial flexibility.
That is a recognizable Buffett-style setup. Rather than chasing volume for its own sake, Occidental has emphasized asset quality, balance-sheet repair, and free-cash-flow resilience. If management can keep production steady, hold costs in line, and avoid overextending the balance sheet, the company does not need peak oil prices to create value.
What the Latest Results Say About Production and Cash Generation
The fourth quarter of 2025 captured both the challenge and the appeal of the story. Occidental posted a net loss attributable to common stockholders of $68 million, or $0.07 per diluted share. But adjusted income attributable to common stockholders was still $315 million, or $0.31 per diluted share, showing that the underlying business remained profitable despite charges tied mainly to the OxyChem sale.
Cash generation stayed solid. Operating cash flow came in at $2.6 billion, or $2.7 billion before working-capital changes. Capital spending including discontinued operations was $1.8 billion, leaving free cash flow before working capital of $1.0 billion.
Operationally, the quarter was better than the income line alone suggests. Total company production averaged 1,481 Mboed, which exceeded the midpoint of guidance by 21 Mboed. Midstream and marketing pre-tax income rose to $204 million from $81 million in the third quarter, a sign that earnings support did not come only from upstream volumes. At year-end 2025, Occidental also reported 4.6 billion BOE of worldwide proved reserves, with a 98% all-in reserves replacement ratio and a 107% organic reserves replacement ratio.
Debt Reduction, Capital Returns, and the Post-OxyChem Setup
The most important strategic update came after quarter-end. Occidental completed the OxyChem sale on January 2, 2026 and said it had reduced debt by $5.8 billion since mid-December 2025, bringing principal debt to $15.0 billion. That changes the shape of the investment case.
A cleaner balance sheet gives management more room to absorb commodity swings without sacrificing capital discipline. It also helps explain why the company raised its quarterly dividend by more than 8% to $0.26 per share. The increase is not the main reason to own the stock, but it signals confidence that debt reduction and operating performance are creating a sturdier base.
Why Oil Sensitivity Still Matters
None of that eliminates the biggest risk: Occidental still has high exposure to realized oil and gas prices. The fourth quarter showed how quickly earnings can compress when prices weaken. That means the stock is unlikely to trade like a stable consumer or insurance compounder even if the long-term asset base is attractive.
There is also execution risk after the OxyChem sale. With less diversification, the upstream and midstream businesses have to keep delivering. If production disappoints, costs rise, or oil prices remain weak for a prolonged period, the balance-sheet improvement alone will not fully protect the equity story.
Still, the latest numbers suggest the bullish case is now less about leverage to a commodity rebound and more about a company that has become financially more durable than it was a few years ago.
Key Signals for Investors
- Q4 2025 adjusted income was $315 million even though reported net income was hit by charges related mainly to the OxyChem sale.
- Operating cash flow was $2.6 billion and free cash flow before working capital was $1.0 billion in Q4 2025.
- Production averaged 1,481 Mboed, above the midpoint of guidance by 21 Mboed.
- Occidental reduced debt by $5.8 billion after the OxyChem sale, bringing principal debt to $15.0 billion.
- The main risk remains the stock’s high sensitivity to oil and gas prices.